findmyKOL
Clinical trialNCT05174767Active, not recruitingInterventional

PERSEVERE- A Trial to Evaluate AMDS in Acute DeBakey Type I Dissection

SponsorArtivion Inc.Enrollment115Acute Aortic Dissection
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

Prospective, non-randomized, multicenter clinical investigation to assess the safety and effectiveness of AMDS in the treatment of patients with acute DeBakey type I dissection, with evidence of malperfusion, through open surgical repair.

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

25 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • University of Alabama at Birmingham

    Birmingham, Alabama, United States

  • University of Southern California

    Los Angeles, California, United States

  • Stanford University

    Palo Alto, California, United States

  • University of Colorado

    Aurora, Colorado, United States

  • Hartford Hospital

    Hartford, Connecticut, United States

  • University of Florida

    Gainesville, Florida, United States

  • Emory University Medical Center

    Atlanta, Georgia, United States

  • Northwestern University

    Chicago, Illinois, United States

  • Massachusetts General Hospital

    Boston, Massachusetts, United States

  • University of Michigan

    Ann Arbor, Michigan, United States

  • Washington University in St. Louis

    St Louis, Missouri, United States

  • Columbia University Irving Medical Center/new York Presbyterian Hospital

    New York, New York, United States

  • Mount Sinai Hospital

    New York, New York, United States

  • Northwell

    New York, New York, United States

  • Montefiore Einstein Medical

    The Bronx, New York, United States

  • Atrium Health Carolinas Medical Center

    Charlotte, North Carolina, United States

  • Cleveland Clinic Foundation

    Cleveland, Ohio, United States

  • Oregon Health and Science University

    Portland, Oregon, United States

  • University of Pennsylvania

    Philadelphia, Pennsylvania, United States

  • University of Pittsburgh Medical Center

    Pittsburgh, Pennsylvania, United States

  • Lankenau Medical Center

    Wynnewood, Pennsylvania, United States

  • Medical University of South Carolina

    Charleston, South Carolina, United States

  • Ascension Seton/university of Texas

    Austin, Texas, United States

  • Baylor College of Medicine/ St. Luke'S Medical Center

    Houston, Texas, United States

  • Baylor Scott & White the Heart Hospital Plano

    Plano, Texas, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
27 May 2022
Primary completion
11 Dec 2023
Completion
6 Dec 2029
Last update posted
15 Jan 2025
Registered enrollment
115
Registry id
NCT05174767

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.